Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy.
Schifitto G, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra CM, Rubin M, Cohen BA, Tucker T, Koralnik IJ, Katzenstein D, Haidich B, Smith ME, Shriver S, Millar L, Clifford DB, McArthur JC; AIDS Clinical Trials Group Team 291.
Schifitto G, et al.
Neurology. 2001 Oct 9;57(7):1313-6. doi: 10.1212/wnl.57.7.1313.
Neurology. 2001.
PMID: 11591856
Clinical Trial.